Lihi Segal on applying technology and predictive models to manage glucose levels
In this episode, we’re diving into the research, and a brand new solution, focused on the growing understanding of the human microbiome – the microorganisms that help protect us against germs, break down food, and produce vitamins.
What work is being done to actually enlist the microbiome in the fight against disease? Can we leverage our understanding not just to preserve health but also to actually prevent or treat metabolic disease? Here on Digital Health today, it is our job and privilege to find the leaders who are breaking new ground, and I’m pleased to introduce you to one of those leaders on this podcast.
With me on this episode is Lihi Segal, the CEO and Co-Founder of DayTwo. Lihi cofounded Day Two in 2015 to bring personalized health solutions based on the gut microbiome into the consumer mainstream. Before starting DayTwo, Lihi led business and financial operations as the COO and CFO of Sisense, which is a provider of business intelligence and analytics software. She’s also a qualified lawyer, and has an LLB from the Tel-Aviv University and an MBA from Northwestern University in the US.
For another episode about the human microbiome, tune into episode 48 where we spoke with Dr. Azza Gadir from Harvard about the relationship between the microbiome and the development and management of food allergies.
This episode of Digital Health Today is made possible thanks to our sponsors. Thank you.
Learn more about your ad choices. Visit megaphone.fm/adchoices